Prosthetic Mitral Valve Obstruction with Left Atrial Appendage Thrombus: A Therapeutic Dilemma.
pannus
prosthetic mitral valve obstruction
thrombolytics
thrombus
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
26 Jun 2019
26 Jun 2019
Historique:
entrez:
10
9
2019
pubmed:
10
9
2019
medline:
10
9
2019
Statut:
epublish
Résumé
Valvular obstruction is a rare but life-threatening complication of mechanical prosthetic valves that raises significant challenges in management. We describe a unique case of mechanical mitral valve obstruction with co-existing left atrial appendage (LAA) thrombus. A 48-year-old man with a past medical history of atrial fibrillation and mechanical mitral valve replacement 18 months prior, presented with symptoms of new onset heart failure for 10 days. INR on presentation was sub-therapeutic. Trans-thoracic and trans-esophageal echocardiography revealed prosthetic mitral valve obstruction with mobile, echogenic masses seen on the mechanical valve as well as LAA, suggestive of thrombus. His clinical course rapidly deteriorated and he developed cardiogenic shock. He was deemed to have prohibitive risk for emergent surgical intervention. He received trial of thrombolytic therapy, with partial improvement of hemodynamic parameters and a mild decrease in thrombus burden. He then underwent surgical intervention with a favorable outcome. Intra-operative visualization of the prosthetic valve revealed a combination of pannus and thrombus. Prosthetic valve function should be promptly assessed in patients presenting with heart failure symptoms, as clinical deterioration can be rapid. Acute presentation, history of inadequate anticoagulation and appearance of soft mass on an echocardiogram, are suggestive of thrombus as the etiology of valve obstruction. However, thrombus and pannus are known to frequently co-exist. Emergent surgery is the recommended management strategy in patients with left-sided prosthetic valve thrombosis with the New York Heart Association (NYHA) III or IV symptoms, due to a lower rate of thrombo-embolism, major bleeding, and recurrent prosthetic valve thrombosis when compared with thrombolytic therapy. Slow-infusion, low-dose thrombolytics were recently shown to have favorable outcomes and can be considered when surgery is not available or the patient is deemed to have prohibitive surgical risk.
Identifiants
pubmed: 31497441
doi: 10.7759/cureus.5011
pmc: PMC6716757
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e5011Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Heart. 2001 Nov;86(5):E16
pubmed: 11602567
J Am Coll Cardiol. 2004 Jan 7;43(1):77-84
pubmed: 14715187
Int J Cardiol. 1992 Jun;35(3):317-22
pubmed: 1612794
J Thromb Thrombolysis. 2006 Apr;21(2):185-90
pubmed: 16622616
Ann Thorac Surg. 1992 Feb;53(2):338-40
pubmed: 1731682
Catheter Cardiovasc Interv. 2008 Aug 1;72(2):151-5
pubmed: 18655116
Arch Cardiovasc Dis. 2009 Apr;102(4):269-77
pubmed: 19427604
Circulation. 2009 Sep 22;120(12):1108-14
pubmed: 19738134
J Am Coll Cardiol. 1991 Mar 1;17(3):646-50
pubmed: 1993782
Am J Cardiol. 2011 Jan 15;107(2):275-9
pubmed: 21211605
Eur Heart J. 2013 Jun;34(21):1557-66
pubmed: 23329151
Circulation. 2013 Jul 30;128(5):532-40
pubmed: 23812180
J Am Coll Cardiol. 2013 Nov 5;62(19):1731-6
pubmed: 23994405
Turk Kardiyol Dern Ars. 2014 Jan;42(1):64-7
pubmed: 24481098
J Am Coll Cardiol. 2014 Jun 10;63(22):e57-185
pubmed: 24603191
Am Heart J. 2015 Aug;170(2):409-18
pubmed: 26299240
J Am Coll Cardiol. 1997 Nov 15;30(6):1521-6
pubmed: 9362411
J Am Coll Cardiol. 1998 Nov;32(5):1410-7
pubmed: 9809956